NewGenIvf Group Limited (NASDAQ:NIVF) Stock Short Interest Climbs 3,427.1%

NewGenIvf Group Limited (NASDAQ:NIVF) saw a significant increase in short interest during the month of October. As of October 15th, there was short interest totaling 2,470,389 shares, an increase of 3,427.1% from the September 30th total of 70,041 shares. Based on an average daily volume of 33,175,029 shares, the short-interest ratio is presently 0.1 days. Approximately 325.1% of the shares of the company are short sold.

NewGenIvf Group Stock Performance

NIVF stock traded down $0.03 during midday trading on Wednesday, reaching $1.12. The company’s stock had a trading volume of 2,359,035 shares, compared to its average volume of 421,704. NewGenIvf Group has a 1 year low of $1.07 and a 1 year high of $20,908.80. The stock has a fifty day simple moving average of $21.58 and a two-hundred day simple moving average of $441.15.

NewGenIvf Group (NASDAQ:NIVF) last issued its quarterly earnings results on Wednesday, October 7th. The company reported ($111.55) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $581.76 by ($693.31). The firm had revenue of $0.96 million during the quarter, compared to analysts’ expectations of $20.10 million. Analysts predict that NewGenIvf Group will post 1365.44 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of analysts recently commented on NIVF shares. Weiss Ratings reiterated a “sell (d)” rating on shares of NewGenIvf Group in a research report on Friday, July 24th. Wall Street Zen downgraded shares of NewGenIvf Group to a “strong sell” rating in a research note on Saturday. One investment analyst has rated the stock with a Sell rating. According to data from MarketBeat.com, the company currently has an average rating of “Sell”.

About NewGenIvf Group

NewGenIvf Group Limited is a reproductive-healthcare company focused on fertility treatment and assisted reproductive technology. Through its operating businesses, the company provides services intended to help individuals and couples pursue pregnancy, including in vitro fertilization (IVF) and related fertility-care procedures.

Its services may include fertility consultations, laboratory-based embryo procedures, intracytoplasmic sperm injection (ICSI), embryo transfer, fertility preservation, and genetic testing or screening associated with assisted reproduction.